文献速递术前评估与围术期医学气道管理

短效与标准麻醉药物对阻塞性睡眠呼吸暂停的影响:随机对照三盲试验

Impact of short-acting vs. standard anaesthetic agents on obstructive sleep apnoea: a randomised, controlled, triple-blind trial.
PubMed 文献 · Anaesthesia · 2020-08-17

主要结局为术后第一夜仰卧位呼吸暂停低通气指数,两组分别为18.9和21.4 events.h⁻¹(p=0.64),无显著差异。结论认为短效麻醉药物并未减少全麻对睡眠呼吸暂停严重程度的影响,提示应更新现有推荐。

要点

  • 短效麻醉药物未降低术后第一夜仰卧位呼吸暂停低通气指数。
  • 术后第三夜及氧减指数等次要睡眠结局两组相似。
  • 术后疼痛评分及吗啡等效消耗量两组总体相似。

核心结论

  • 与标准药物相比,短效麻醉药物并未减少全麻对睡眠呼吸暂停严重程度的影响。
  • 这些数据提示应更新当前推荐。

研究设计与样本

  • 随机分为地氟烷-瑞芬太尼组或七氟烷-芬太尼组。
  • 术前及术后第一夜、第三夜进行呼吸多导睡眠图监测。

主要发现

  • 术后第一夜仰卧位呼吸暂停低通气指数:短效组18.9(95%CI 12.7-25.0)events.h⁻¹,标准组21.4(95%CI 14.2-28.7)events.h⁻¹,p=0.64。
  • 术后第三夜仰卧位呼吸暂停低通气指数:短效组28.1(95%CI 15.8-40.3)events.h⁻¹,标准组38.0(95%CI 18.3-57.6)events.h⁻¹,p=0.34。
  • 两组术后第一夜和第三夜氧减指数及疼痛相关结局总体相似。
  • 术前睡眠研究数据两组相似。

临床怎么用

  • 对于阻塞性睡眠呼吸暂停患者,不应仅依据短效药物可减轻术后呼吸暂停严重程度这一假设来选择麻醉药物。
  • 围术期应继续关注睡眠呼吸暂停患者的术后呼吸监测与管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sleep apnoea is associated with negative outcomes following general anaesthesia. Current recommendations suggest using short-acting anaesthetic agents in preference to standard agents to reduce this risk, but there is currently no evidence to support this. This randomised controlled triple-blind trial tested the hypothesis that a combination of short-acting agents (desflurane-remifentanil) would reduce the postoperative impact of general anaesthesia on sleep apnoea severity compared with standard agents (sevoflurane-fentanyl). Sixty patients undergoing hip arthroplasty under general anaesthesia were randomised to anaesthesia with desflurane-remifentanil or sevoflurane-fentanyl. Respiratory polygraphy was performed before surgery and on the first and third postoperative nights. The primary outcome was the supine apnoea-hypopnoea index on the first postoperative night. Secondary outcomes were the supine apnoea-hypopnoea index on the third postoperative night, and the oxygen desaturation index on the first and third postoperative nights. Additional outcomes included intravenous morphine equivalent consumption and pain scores on postoperative days 1, 2 and 3. Pre-operative sleep study data were similar between groups. Mean (95%CI) values for the supine apnoea-hypopnoea index on the first postoperative night were 18.9 (12.7-25.0) and 21.4 (14.2-28.7) events.h-1 , respectively, in the short-acting and standard anaesthesia groups (p = 0.64). Corresponding values on the third postoperative night were 28.1 (15.8-40.3) and 38.0 (18.3-57.6) events.h-1 (p = 0.34). Secondary sleep- and pain-related outcomes were generally similar in the two groups. In conclusion, short-acting anaesthetic agents did not reduce the impact of general anaesthesia on sleep apnoea severity compared with standard agents. These data should prompt an update of current recommendations.

来源:Anaesthesia,查看原文。版权归原作者所有。

引用

  1. Albrecht E, Bayon V, Hirotsu C, et al. Impact of short-acting vs. standard anaesthetic agents on obstructive sleep apnoea: a randomised, controlled, triple-blind trial. Anaesthesia. 2020. PMID: 33253427. doi:10.1111/anae.15236

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。